Walker-Warburg congenital muscular dystrophy
|
0.720 |
GeneticVariation
|
disease |
BEFREE |
These findings emphasize the importance of considering MEB and searching for POMGnT1 mutations in WWS or other congenital muscular dystrophy patients worldwide.
|
12588800 |
2003 |
Walker-Warburg congenital muscular dystrophy
|
0.720 |
GeneticVariation
|
disease |
BEFREE |
Walker-Warburg Syndrome (WWS) and muscle-eye-brain disease (MEB) are caused by mutations in two genes involved in O-mannosylation, POMT1 and POMGnT1, respectively.
|
12925572 |
2003 |
Muscle eye brain disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
We report new POMGnT1 mutations and evaluate protein expression in 3 patients and 2 foetuses with variably severe MEB features.
|
22554691 |
2012 |
Muscle eye brain disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Novel copy number variation of POMGNT1 associated with muscle-eye-brain disease detected by next-generation sequencing.
|
28765568 |
2017 |
Muscle eye brain disease
|
0.700 |
Biomarker
|
disease |
BEFREE |
CMDs associated with brain malformations such as MEB, WWS and FCMD are heterogenous in clinical presentation and on radiologic examination, suggesting that POMGnT1 assays of muscle biopsies should be used as a screening procedure for MEB in all CMD patients associated with brain malformations.
|
12849864 |
2003 |
Muscle eye brain disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Clinical features and molecular characterization of a patient with muscle-eye-brain disease: a novel mutation in the POMGNT1 gene.
|
24282183 |
2014 |
Muscle eye brain disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Both linkage analysis of the POMGNT1/1p32-p34 region and direct sequencing for the novel familial mutation (R605H) demonstrated that the fetus did not have MEB.
|
17154333 |
2007 |
Muscle eye brain disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Severe muscle-eye-brain disease is associated with a homozygous mutation in the POMGnT1 gene.
|
17881266 |
2008 |
Muscle eye brain disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Muscle-eye-brain disease is a congenital muscular dystrophy with eye and brain involvement due to POMGnT1 mutations.
|
17030669 |
2006 |
Muscle eye brain disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Walker-Warburg Syndrome (WWS) and muscle-eye-brain disease (MEB) are caused by mutations in two genes involved in O-mannosylation, POMT1 and POMGnT1, respectively.
|
12925572 |
2003 |
Muscle eye brain disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Biochemical correlation of activity of the α-dystroglycan-modifying glycosyltransferase POMGnT1 with mutations in muscle-eye-brain disease.
|
21361872 |
2011 |
Muscle eye brain disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Congenital muscular dystrophy patients from Turkey carrying the clinical and radiologic features of muscle-eye-brain disease should be evaluated for mutations in POMGNT1 gene.
|
24731844 |
2014 |
Muscle eye brain disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Novel POMGnT1 mutations define broader phenotypic spectrum of muscle-eye-brain disease.
|
17906881 |
2007 |
Muscle eye brain disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
We subsequently found that loss of function of the POMGnT1 gene is responsible for muscle-eye-brain disease (MEB).
|
14646163 |
2003 |
Muscle eye brain disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
We also identified six independent mutations of the POMGnT1 gene in six patients with MEB.
|
11709191 |
2001 |
Muscle eye brain disease
|
0.700 |
Biomarker
|
disease |
BEFREE |
Expression pattern in retinal photoreceptors of POMGnT1, a protein involved in muscle-eye-brain disease.
|
27375352 |
2016 |
Muscle eye brain disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Mutations in protein-O-mannose-beta1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) have been found in muscle-eye-brain disease, a congenital muscular dystrophy with structural eye and brain defects and severe mental retardation.
|
18195152 |
2008 |
Muscle eye brain disease
|
0.700 |
Biomarker
|
disease |
BEFREE |
These results clearly demonstrate that MEB is inherited as a loss-of-function of POMGnT1.
|
12788071 |
2003 |
Muscle eye brain disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
These findings emphasize the importance of considering MEB and searching for POMGnT1 mutations in WWS or other congenital muscular dystrophy patients worldwide.
|
12588800 |
2003 |
Muscle eye brain disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Novel POMGnT1 mutations cause muscle-eye-brain disease in Chinese patients.
|
23689641 |
2013 |
Muscular Dystrophies, Limb-Girdle
|
0.340 |
GeneticVariation
|
group |
BEFREE |
In contrast mutations in fukutin and POMGnT1 were detected in four patients with LGMD and no evidence of brain involvement.
|
17878207 |
2007 |
Muscular Dystrophies, Limb-Girdle
|
0.340 |
GeneticVariation
|
group |
BEFREE |
Promoter alteration causes transcriptional repression of the POMGNT1 gene in limb-girdle muscular dystrophy type 2O.
|
22419172 |
2012 |
Muscular Dystrophies, Limb-Girdle
|
0.340 |
GeneticVariation
|
group |
BEFREE |
Our findings widen the spectrum of disorders known to result from mutations in POMGnT1 to include limb-girdle muscular dystrophy with no mental retardation.
|
18195152 |
2008 |
Muscular Dystrophies, Limb-Girdle
|
0.340 |
Biomarker
|
group |
BEFREE |
The secondary α-dystroglycanopathies usually present in infancy as congenital muscular dystrophies but may manifest later in childhood or adult life (limb-girdle muscular dystrophy (LGMD) 2I, LGMD2K, LGMD2M, LGMD2N, and LGMD2O).
|
21496628 |
2011 |
alpha-Dystroglycanopathies
|
0.330 |
Biomarker
|
disease |
BEFREE |
At present, of the six proteins involved on alpha-dystroglycanopathies, the function of the gene products is only known for POMT1, POMT2, and POMGnT1, all responsible for the O-mannosylglycan biosynthesis.
|
20816175 |
2010 |